229 related articles for article (PubMed ID: 16168468)
1. Germline polymorphism of p53 codon 72 in gynecological cancer.
Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M
Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468
[TBL] [Abstract][Full Text] [Related]
2. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
[TBL] [Abstract][Full Text] [Related]
3. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.
Granja F; Morari J; Morari EC; Correa LA; Assumpção LV; Ward LS
Cancer Lett; 2004 Jul; 210(2):151-7. PubMed ID: 15183530
[TBL] [Abstract][Full Text] [Related]
4. The p53 codon 72 polymorphism and lung cancer risk.
Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
[TBL] [Abstract][Full Text] [Related]
5. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
[TBL] [Abstract][Full Text] [Related]
6. Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients.
Høgdall EV; Høgdall CK; Christensen L; Glud E; Blaakaer J; Bock JE; Vuust J; Nørgaard-Pedersen B; Kjaer SK
Anticancer Res; 2002; 22(3):1859-64. PubMed ID: 12168882
[TBL] [Abstract][Full Text] [Related]
7. p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia.
Malisic E; Jankovic R; Slavkovic D; Milovic-Kovacevic M; Radulovic S
J BUON; 2010; 15(1):101-6. PubMed ID: 20414935
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer].
Li CY; Liu JH; Huang BJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643
[TBL] [Abstract][Full Text] [Related]
9. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
Damin AP; Frazzon AP; Damin DC; Roehe A; Hermes V; Zettler C; Alexandre CO
Cancer Detect Prev; 2006; 30(6):523-9. PubMed ID: 17113725
[TBL] [Abstract][Full Text] [Related]
10. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of p53 gene codon 72 in Kuwaiti with coronary artery disease and diabetes.
Alkhalaf M; Al-Bustan S; Hamoda H; Abdella N
Int J Cardiol; 2007 Jan; 115(1):1-6. PubMed ID: 16797751
[TBL] [Abstract][Full Text] [Related]
12. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population].
Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):76-9. PubMed ID: 15774209
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism at codon 72 of the p53 gene is not associated with endometriosis in a Japanese population.
Omori S; Yoshida S; Kennedy SH; Negoro K; Hamana S; Barlow DH; Maruo T
J Soc Gynecol Investig; 2004 May; 11(4):232-6. PubMed ID: 15120697
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer.
Ghasemi N; Karimi-Zarchi M; Mortazavi-Zadeh MR; Atash-Afza A
Cancer Genet Cytogenet; 2010 Jan; 196(2):167-70. PubMed ID: 20082853
[TBL] [Abstract][Full Text] [Related]
15. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
[TBL] [Abstract][Full Text] [Related]
16. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
Noma C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2004 Jul; 210(2):197-203. PubMed ID: 15183535
[TBL] [Abstract][Full Text] [Related]
17. Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habits.
Pandima Devi K; Sivamaruthi B; Kiruthiga PV; Karutha Pandian S
Hum Exp Toxicol; 2010 Jun; 29(6):451-8. PubMed ID: 19948747
[TBL] [Abstract][Full Text] [Related]
18. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
[TBL] [Abstract][Full Text] [Related]
19. Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma.
Boltze C; Roessner A; Landt O; Szibor R; Peters B; Schneider-Stock R
Int J Oncol; 2002 Nov; 21(5):1151-4. PubMed ID: 12370767
[TBL] [Abstract][Full Text] [Related]
20. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
Wang YC; Chen CY; Chen SK; Chang YY; Lin P
Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
